EUVIMEDEUVIMED entdecken
Open Access

Abdominal adiposity and Alzheimer's disease imaging markers across sex and race at midlife

Mahsa Dolatshahi iD, Paul K Commean, Mahshid Naghashzadeh, Sara Hosseinzadeh Kassani, Farzaneh Rahmani, Yifei Xu, Jingxia Liu iD, Soheil Mohammadi iD, Lakisha Lloyd, Caitlyn Nguyen, Abby Mcbee Kemper, Nancy Hantler und 12 weitere

Journal of Alzheimer’s Disease · 2026

DOI: 10.1177/13872877261455657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2026. Verfasst von Mahsa Dolatshahi und 23 weiteren Autor:innen. Beteiligte Einrichtung: Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, MO, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Adiposity, Obesity, Abdominal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDDK NIH HHS, FDA HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Midlife obesity is considered one of the top modifiable risk factors for dementia and Alzheimer's disease (AD). However, body mass index (BMI) on its own does not fully represent obesity-associated risks and it is crucial to disentangle the role of body adiposity and its localization.

Objective

To investigate the relationship of MRI-derived body adiposity metrics with AD-related pathology at midlife.

Methods

Ninety-seven cognitively normal midlife individuals underwent brain amyloid and tau PET, body MRI, and metabolic and cognitive assessments. Key measures included hepatic fat fraction, visceral (VAT) and subcutaneous adipose tissue (SAT) volumes, and thigh muscle and adiposity. The correlation between adiposity/metabolic measurements and amyloid/tau pathologies was investigated.

Results

The average age of participants was 49.8 years, 65.3% were female and 53.6% had obesity. Amyloid PET burden in Centiloids correlated with VAT (rho = 0.36, p = 0.002), BMI (rho = 0.33, p = 0.002), SAT (rho = 0.33, p = 0.002), and insulin resistance (IR) (rho = 0.34, p = 0.003) in females and Whites, lower high-density lipoprotein (HDL) cholesterol (rho = −0.36, p = 0.002) irrespective of sex and race, and lower MMSE scores (rho = −0.57, p = 0.043) in only in African-Americans, after correction for age, sex, and education. There was no evidence that HDL nor IR mediated VAT-related amyloid. VAT/SAT ratio was significantly associated with mean cortical tau SUVR (β = 0.138, p = 0.030) after adjustment for age, sex, education, and amyloid.

Conclusions

Among fat depots in our study, visceral fat was more strongly correlated to amyloid pathology, and this association is present even independent from BMI. Also, higher visceral compared to subcutaneous fat is related to higher tau pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAdiposityObesity, AbdominalHumansFemaleMaleMiddle AgedPositron-Emission TomographyMagnetic Resonance ImagingBody Mass IndexBrainAmyloid beta-PeptidesObesity

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid-βmidlifeobesityvisceral fat

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, MO, USA.
  • Division of Public Health Sciences, Department of Surgery, Washington University in St Louis School of Medicine, St Louis, MO, USA.
  • Department of Radiology, Liver Imaging Group, University of California, San Diego, La Jolla, CA, USA.
  • Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Department of Computer Science, State University of New York at Binghamton, State University of New York at Binghamton, Binghamton, NY, USA.
  • Departments of Medicine and Nutrition & Exercise Physiology, University of Missouri School of Medicine, University of Missouri School of Medicine, Columbia, MO, USA.

ORCID-Profile: Mahsa Dolatshahi, Jingxia Liu, Soheil Mohammadi, Cyrus A Raji

Förderung

  • NIA NIH HHS
  • NIDDK NIH HHS
  • FDA HHS
  • NIBIB NIH HHS
  • National Institute on Aging

Zitieren

APA

Dolatshahi, M., Commean, P. K., Naghashzadeh, M., Kassani, S. H., Rahmani, F., Xu, Y., Liu, J., Mohammadi, S., Lloyd, L., Nguyen, C., Kemper, A. M., Hantler, N., Flores, S., Weeks, J., Ceriani, L. K., Sirlin, C. B., Ippolito, J. E., Dai, W., Mittendorfer, B., …, & Raji, C. A. (2026). Abdominal adiposity and Alzheimer's disease imaging markers across sex and race at midlife. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261455657

Vancouver

Dolatshahi M, Commean PK, Naghashzadeh M, Kassani SH, Rahmani F, Xu Y, et al. Abdominal adiposity and Alzheimer's disease imaging markers across sex and race at midlife. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261455657

BibTeX
@article{Dolatshahi2026,
  author = {Dolatshahi, Mahsa and Commean, Paul K and Naghashzadeh, Mahshid and Kassani, Sara Hosseinzadeh and Rahmani, Farzaneh and Xu, Yifei and Liu, Jingxia and Mohammadi, Soheil and Lloyd, Lakisha and Nguyen, Caitlyn and Kemper, Abby Mcbee and Hantler, Nancy and Flores, Shaney and Weeks, Jake and Ceriani, Lael K and Sirlin, Claude B and Ippolito, Joseph E and Dai, Weiying and Mittendorfer, Bettina and Schindler, Suzanne E and Brier, Matthew R and Morris, John C and Benzinger, Tammie L S and Raji, Cyrus A},
  title = {Abdominal adiposity and Alzheimer's disease imaging markers across sex and race at midlife},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261455657}
}
Kostenlos starten →